Therapeutic down-regulation of central and peripheral B-cell-activating factor (BAFF) production in pediatric opsoclonus-myoclonus syndrome

Cytokine

Volumn 44, Issue 1, 2008, Pages 26-32

  Pranzatelli, Michael R ^a   Tate, Elizabeth D ^a   Hoefgen, Erik R ^a   Swan, Jennifer A ^a   Colliver, Jerry A ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Ataxia; Cerebrospinal fluid; Corticotropin; Neuroblastoma; Paraneoplastic syndrome

Indexed keywords

AUTOANTIBODY; B CELL ACTIVATING FACTOR; CORTICOTROPIN; IMMUNOGLOBULIN; PREDNISONE;

ADOLESCENT; ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ARTICLE; ASTROCYTE; AUTOIMMUNE DISEASE; B LYMPHOCYTE ACTIVATION; CASE CONTROL STUDY; CEREBROSPINAL FLUID; CHILD; CONTROLLED STUDY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMORAL IMMUNITY; IMMUNOTHERAPY; INFANT; LYMPHOCYTE SUBPOPULATION; MAJOR CLINICAL STUDY; MALE; OPSOCLONUS MYOCLONUS SYNDROME; PARANEOPLASTIC SYNDROME; PRIORITY JOURNAL; PROSPECTIVE STUDY; T LYMPHOCYTE;

ADOLESCENT; ADRENOCORTICOTROPIC HORMONE; ADULT; B-CELL ACTIVATING FACTOR; CHILD; CHILD, PRESCHOOL; DOWN-REGULATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOTHERAPY; INFANT; MALE; OPSOCLONUS-MYOCLONUS SYNDROME; STEROIDS;

EID: 53149103899     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2008.06.001     Document Type: Article

References (29)

1. Bergamin F., Vincent I.E., Summerfield A., and McCullough K.C. Essential role of antigen-presenting cell-derived BAFF for antibody responses. Eur J Immunol (2007) [Epub ahead of print]
2. Day E.S., Cachero T.G., Qian F., Sun Y., Wen D., Pelletier M., et al. Selectivity of BAFF/BLyS and APRIL for binding to the TNF family receptors BAFFR/BR3 and BCMA. Biochemistry 44 (2005) 1919-1931
3. Krumbholz M., Theil D., Derfuss T., Rosenwald A., Schrader F., Monoranu C., et al. BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma. J Exp Med 201 (2005) 195-200 [Epub 2005 Jan 10]
4. Fabris M., Visentini D., De Re V., Picierno A., Maieron R., Cannizzaro R., et al. Elevated B cell-activating factor of the tumour necrosis factor family in celiac disease. Scand J Gastroenterol (2007) 1-6 Epub ahead of print
5. Mackay F., and Tangye S.G. The role of the BAFF/APRIL system in B cell homeostasis and lymphoid cancers. Curr Opin Pharmacol 4 (2004) 347-354
6. Szodoray P., and Jonsson R. The BAFF/APRIL system in systemic autoimmune diseases with a special emphasis on Sjögren's syndrome. Scand J Immunol 62 (2005) 421-428
7. Mackay F., Silveira P.A., and Brink R. B cells and the BAFF/APRIL axis: fast-forward on autoimmunity and signaling. Curr Opin Immunol 19 (2007) 327-336
8. Pranzatelli M.R. Opsoclonus-myoclonus-ataxia. In: Fernandez-Alvarez E., Arzimanoglou A., and Tolosa E. (Eds). Pediatric movement disorders (2005), John Libbey Eurotext, Montrouge, France 120-136
9. Tate E.D., Allison T.J., Pranzatelli M.R., and Verhulst S.J. Neuroepidemiologic trends in 105 U.S. cases of pediatric opsoclonus-myoclonus. J Pediatr Oncol Nurs 22 (2005) 8-19
10. Pranzatelli M.R., Travelstead A., Tate E.D., Allison T.J., Moticka E.J., Franz D.N., et al. B- and T-cell markers in opsoclonus-myoclonus syndrome: immunophenotyping of CSF lymphocytes. Neurology 62 (2004) 1526-1532
11. Pranzatelli M.R., Travelstead A.L., Tate E.D., Allison T.J., and Verhulst S.J. CSF B-cell expansion in opsoclonus-myoclonus syndrome: a biomarker of disease activity. Mov Disord 19 (2004) 770-777
12. Pranzatelli M.R., Tate E.D., Travelstead A.L., Barbosa J., Bergamini R.A., Civitello L., et al. Rituximab (anti-CD20) adjunctive therapy for opsoclonus-myoclonus syndrome. J Pediatr Hematol Oncol 28 (2006) 585-593
13. Pranzatelli M.R. The immunopharmacology of the opsoclonus-myoclonus syndrome. Clin Neuropharmacol 19 (1996) 1-47
14. Pranzatelli M.R., Huang Y.Y., Tate E., Goldstein D.S., Holmes C.S., Goldstein E.M., et al. Monoaminergic effects of high dose corticotropin corticotropin-responsive pediatric opsoclonus-myoclonus. Mov Disord 13 (1998) 522-528
15. Jayabose S., Levendoglu-Tugal O., Giamelli J., Grodin W., Cohn M., Sandoval C., et al. Intravenous anesthesia with propofol for painful procedures in children with cancer. J Pediatr Hematol Oncol 23 (2001) 290-293
16. Tate E.D., Pranzatelli M.R., Huang Y., and Kaplan R. An innovative approach to the problem of sedating children with opsoclonus-myoclonus syndrome: effects on myoclonus and CSF monoamine metabolites. Ann Neurol 36 (1994) 543-544
17. Kokki H., Turunen M., Heikkinen M., Reinikainen M., and Laisalmi M. High success rate and low incidence of headache and neurological symptoms with two spinal needle designs in children. Acta Anaesthesiol Scand 49 (2005) 1367-1372
18. Emmerich F., Bal G., Barakat A., Milz J., Mühle C., Martinez-Gamboa L., et al. High-level serum B-cell activating factor and promoter polymorphisms in patients with idiopathic thrombocytopenic purpura. Br J Haematol 136 (2006) 309-314
19. Farina C., Aloisi F., and Meinl E. Astrocytes are active players in cerebral innate immunity. Trends Immunol 28 (2007) 138-145 [Epub 2007 Feb 2. Review]
20. Zohar M., and Salomon Y. Melanocortins stimulate proliferation and induce morphological changes in cultured rat astrocytes by distinct transducing mechanisms. Brain Res 576 (1992) 49-58
21. Pranzatelli M.R. On the molecular mechanism of adrenocorticotrophic hormone: neurotransmitters and receptors. Exp Neurol 125 (1994) 142-161
22. Pranzatelli M.R., Chun K.Y., Moxness M., Tate E.D., and Allison T.J. Cerebrospinal fluid ACTH and cortisol in opsoclonus-myoclonus: effect of therapy. Pediatr Neurol 33 (2005) 121-126
23. Bohn M.C., Howard E., Vielkind U., and Krozowski Z. Glial cells express both mineralocorticoid and glucocorticoid receptors. J Steroid Biochem Mol Biol 40 (1991) 105-111
24. Ng L.G., Sutherland A.P.R., Newton R., Qian F., Cachero T.G., Scott M.L., et al. B cell-activating factor belonging to the TNF family (BAFF)-R is the principal BAFF receptor facilitating BAFF costimulation of circulating T and B cells. J Neuroimmunol 173 (2004) 807-817
25. Pers J.O., Daridon C., Devauchelle V., Jousse S., Saraux A., Jamin C., et al. BAFF overexpression is associated with autoantibody production in autoimmune diseases. Ann NY Acad Sci 1050 (2005) 34-39
26. Krumbholz M., Specks U., Wick M., Kalled S.L., Jenne D., and Meinl E. BAFF is elevated in serum of patients with Wegener's granulomatosis. J Autoimmun 25 (2005) 298-302 [Epub 2005 Oct 20]
27. Kang J.S., Yoon Y.D., Ahn J.H., Kim S.C., Kim K.H., Kim H.M., et al. B cell-activating factor is a novel diagnosis parameter for asthma. Int Arch Allergy Immunol 141 (2006) 181-188
28. Sarantopoulos S., Stevenson K.E., Kim H.T., Bhuiya N.S., Cutler C.S., Soiffer R.J., et al. High levels of B-cell activating factor in patients with active chronic graft-versus-host disease. Clin Cancer Res 13 (2007) 6107-6114
29. Le Pottier L., Sapir T., Bendaoud B., Youinou P., Shoenfeld Y., and Pers J. Intravenous immunoglobulin and cytokines: focus on tumor necrosis factor family members BAFF and APRIL. Ann NY Acad Sci 1110 (2007) 426-432